RU95105449A - Пероральный препарат морфина с регулируемым выделением активного компонента - Google Patents
Пероральный препарат морфина с регулируемым выделением активного компонентаInfo
- Publication number
- RU95105449A RU95105449A RU95105449/14A RU95105449A RU95105449A RU 95105449 A RU95105449 A RU 95105449A RU 95105449/14 A RU95105449/14 A RU 95105449/14A RU 95105449 A RU95105449 A RU 95105449A RU 95105449 A RU95105449 A RU 95105449A
- Authority
- RU
- Russia
- Prior art keywords
- morphine
- preparation
- oral preparation
- active component
- component releasing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Abstract
Изобретение относится к пероральному препарату морфина, имеющему полную биологическую доступность и, для растворения основного количества, нулевой порядок и независимо от рН выделение морфина в течение по меньшей мере 8 ч, предпочтительно по меньшей мере 12 ч, в течение которых растворяется меньше 100%. В препарате морфин в форме легкорастворимой соли находится в смеси с буферным агентом, и препарат покрыт диффузионной мембраной.
Claims (1)
- Изобретение относится к пероральному препарату морфина, имеющему полную биологическую доступность и, для растворения основного количества, нулевой порядок и независимо от рН выделение морфина в течение по меньшей мере 8 ч, предпочтительно по меньшей мере 12 ч, в течение которых растворяется меньше 100%. В препарате морфин в форме легкорастворимой соли находится в смеси с буферным агентом, и препарат покрыт диффузионной мембраной.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9202250A SE9202250D0 (sv) | 1992-07-29 | 1992-07-29 | Controlled release morphine preparation |
SE9202250-8 | 1992-07-29 | ||
PCT/SE1993/000642 WO1994003161A1 (en) | 1992-07-29 | 1993-07-28 | Controlled release morphine preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95105449A true RU95105449A (ru) | 1997-06-10 |
RU2114613C1 RU2114613C1 (ru) | 1998-07-10 |
Family
ID=20386851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95105449A RU2114613C1 (ru) | 1992-07-29 | 1993-07-28 | Пероральный препарат морфина с регулируемым выделением активного компонента |
Country Status (22)
Country | Link |
---|---|
US (1) | US5520931A (ru) |
EP (1) | EP0652747B1 (ru) |
JP (2) | JPH08501081A (ru) |
KR (1) | KR0156038B1 (ru) |
CN (1) | CN1053339C (ru) |
AT (1) | ATE176398T1 (ru) |
AU (1) | AU662239B2 (ru) |
CA (1) | CA2140254C (ru) |
DE (1) | DE69323428T2 (ru) |
DK (1) | DK0652747T3 (ru) |
ES (1) | ES2130278T3 (ru) |
FI (1) | FI950319A (ru) |
GR (1) | GR3030106T3 (ru) |
HU (1) | HU221683B1 (ru) |
IL (1) | IL106477A (ru) |
NO (1) | NO307407B1 (ru) |
NZ (1) | NZ254314A (ru) |
PL (1) | PL172571B1 (ru) |
RU (1) | RU2114613C1 (ru) |
SE (1) | SE9202250D0 (ru) |
WO (1) | WO1994003161A1 (ru) |
ZA (1) | ZA935488B (ru) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
GB2288117A (en) * | 1994-03-01 | 1995-10-11 | Euro Celtique Sa | Sustained release morphine |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
GB2284760B (en) * | 1993-11-23 | 1998-06-24 | Euro Celtique Sa | A method of preparing pharmaceutical compositions by melt pelletisation |
US20080075781A1 (en) * | 1992-11-25 | 2008-03-27 | Purdue Pharma Lp | Controlled release oxycodone compositions |
US5656291A (en) * | 1994-03-16 | 1997-08-12 | Pharmacia & Upjohn Aktiebolag | Controlled release preparation |
SE9301057L (sv) † | 1993-03-30 | 1994-10-01 | Pharmacia Ab | Beredning med kontrollerad frisättning |
US20070275062A1 (en) * | 1993-06-18 | 2007-11-29 | Benjamin Oshlack | Controlled release oxycodone compositions |
US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
IL109944A (en) † | 1993-07-01 | 1998-12-06 | Euro Celtique Sa | Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms |
US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
GB9519363D0 (en) | 1995-09-22 | 1995-11-22 | Euro Celtique Sa | Pharmaceutical formulation |
EA001773B1 (ru) * | 1996-03-08 | 2001-08-27 | Нюкомед Данмарк А/С | Пероральная фармацевтическая форма лекарственного препарата в виде множественной дозированной формы с модифицированным высвобождением |
US6066339A (en) * | 1997-10-17 | 2000-05-23 | Elan Corporation, Plc | Oral morphine multiparticulate formulation |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
EP2269587A1 (en) | 1999-10-29 | 2011-01-05 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
US6469030B2 (en) | 1999-11-29 | 2002-10-22 | Adolor Corporation | Methods for the treatment and prevention of ileus |
AU2738302A (en) | 2000-10-30 | 2002-05-15 | Euro Celtique Sa | Controlled release hydrocodone formulations |
US20030175349A1 (en) * | 2001-01-30 | 2003-09-18 | Council Of Scientific And Industrial Research | Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient |
US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
UA81224C2 (ru) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозированная форма оксикодона и ее применение |
US20040253310A1 (en) | 2001-09-21 | 2004-12-16 | Gina Fischer | Morphine polymer release system |
US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
EP1450824A4 (en) * | 2001-11-02 | 2005-09-28 | Elan Corp Plc | PHARMACEUTICAL COMPOSITION |
GB0203296D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
US8637512B2 (en) * | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
CA2498798A1 (en) * | 2002-09-20 | 2004-04-01 | Alpharma, Inc. | Sustained-release opioid formulations and methods of use |
US8487002B2 (en) * | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
TWI319713B (en) * | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
MXPA05004648A (es) * | 2002-10-30 | 2005-06-08 | Pharmacia Corp | Comprimidos orales de liberacion extendida y procedimientos de preparacion y uso de los mismos. |
ATE495732T1 (de) | 2003-03-26 | 2011-02-15 | Egalet As | Morphin-system mit kontrollierter freisetzung |
US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
JP5269595B2 (ja) * | 2005-09-09 | 2013-08-21 | アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー | 1日1回投与用トラゾドン組成物 |
US8161977B2 (en) | 2006-01-31 | 2012-04-24 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US20070190141A1 (en) * | 2006-02-16 | 2007-08-16 | Aaron Dely | Extended release opiate composition |
WO2008011596A2 (en) * | 2006-07-21 | 2008-01-24 | Lab International Srl | Hydrophilic abuse deterrent delivery system |
US20080220064A1 (en) * | 2006-12-06 | 2008-09-11 | Ramesh Ketkar Anant | Extended release matrix formulations of morphine |
EP2155167A2 (en) | 2007-06-04 | 2010-02-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
JP5302589B2 (ja) * | 2007-07-26 | 2013-10-02 | 興和株式会社 | イブプロフェン及びトラネキサム酸含有固形製剤 |
NZ594207A (en) | 2009-02-06 | 2013-03-28 | Egalet Ltd | Immediate release composition resistant to abuse by intake of alcohol |
EP3045043B1 (en) | 2009-02-26 | 2020-04-29 | Relmada Therapeutics, Inc. | Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use |
NZ603579A (en) | 2009-06-24 | 2014-02-28 | Egalet Ltd | Controlled release formulations |
CA2877183A1 (en) | 2012-07-06 | 2014-01-09 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
WO2018208241A1 (en) | 2017-05-10 | 2018-11-15 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Formulation and optimization of controlled release tablets of morphine sulphate |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE295548C (ru) * | ||||
US4461598A (en) * | 1982-02-08 | 1984-07-24 | Flechs Ronald D | Machine for installing drip irrigation conduit |
US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
US4557925A (en) * | 1982-07-08 | 1985-12-10 | Ab Ferrosan | Membrane-coated sustained-release tablets and method |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
GB8514665D0 (en) * | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
JPS62283926A (ja) * | 1986-06-02 | 1987-12-09 | Nippon Chemiphar Co Ltd | 塩酸ニカルジピン持続性組成物 |
US4970075A (en) * | 1986-07-18 | 1990-11-13 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
IE64726B1 (en) * | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
US5178868A (en) * | 1988-10-26 | 1993-01-12 | Kabi Pharmacia Aktiebolaq | Dosage form |
SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
-
1992
- 1992-07-29 SE SE9202250A patent/SE9202250D0/xx unknown
-
1993
- 1993-07-26 IL IL10647793A patent/IL106477A/en not_active IP Right Cessation
- 1993-07-28 AU AU45955/93A patent/AU662239B2/en not_active Expired
- 1993-07-28 WO PCT/SE1993/000642 patent/WO1994003161A1/en active IP Right Grant
- 1993-07-28 PL PL93307262A patent/PL172571B1/pl not_active IP Right Cessation
- 1993-07-28 DE DE69323428T patent/DE69323428T2/de not_active Expired - Lifetime
- 1993-07-28 NZ NZ254314A patent/NZ254314A/en not_active IP Right Cessation
- 1993-07-28 RU RU95105449A patent/RU2114613C1/ru not_active IP Right Cessation
- 1993-07-28 EP EP93916380A patent/EP0652747B1/en not_active Expired - Lifetime
- 1993-07-28 HU HU9500260A patent/HU221683B1/hu not_active IP Right Cessation
- 1993-07-28 AT AT93916380T patent/ATE176398T1/de not_active IP Right Cessation
- 1993-07-28 JP JP6505225A patent/JPH08501081A/ja active Pending
- 1993-07-28 CA CA002140254A patent/CA2140254C/en not_active Expired - Lifetime
- 1993-07-28 DK DK93916380T patent/DK0652747T3/da active
- 1993-07-28 ES ES93916380T patent/ES2130278T3/es not_active Expired - Lifetime
- 1993-07-28 KR KR1019950700300A patent/KR0156038B1/ko not_active IP Right Cessation
- 1993-07-29 ZA ZA935488A patent/ZA935488B/xx unknown
- 1993-07-29 CN CN93118344A patent/CN1053339C/zh not_active Expired - Fee Related
-
1995
- 1995-01-04 US US08/362,526 patent/US5520931A/en not_active Expired - Lifetime
- 1995-01-25 FI FI950319A patent/FI950319A/fi unknown
- 1995-01-27 NO NO950318A patent/NO307407B1/no unknown
-
1999
- 1999-04-30 GR GR990401188T patent/GR3030106T3/el unknown
-
2005
- 2005-12-28 JP JP2005377119A patent/JP4976011B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95105449A (ru) | Пероральный препарат морфина с регулируемым выделением активного компонента | |
AU6770490A (en) | Solid pharmaceutical compositions containing cimetidine | |
RU94035739A (ru) | Фармацевтическая композиция, содержащая нифедипин, и способ ее получения | |
CA2225286A1 (en) | A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof | |
IE883810L (en) | Sustained release pharmaceutical compositions | |
AU7495596A (en) | Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process | |
MY114388A (en) | Multiple unit pharmaceutical preparation | |
CA2033725A1 (en) | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid | |
CA2016039A1 (en) | Extended release pharmaceutical formulations | |
CA2075876A1 (fr) | Nouveaux derives d'arylethylamines, leurs procedes de preparation et lescompositions pharmaceutiques qui les contiennent | |
CA2126611A1 (en) | Opiod Formulations Having Extended Controlled Release | |
ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
EP0173664A3 (en) | Biologically active benzimidazole compounds and process for their preparation | |
NZ227990A (en) | Cephemcarboxylic acid esters; pharmaceutical compositions and processes for preparation | |
ATE326217T1 (de) | Verfahren zur herstellung einer schwimmfähigen tablette mit alfuzosin | |
MY129946A (en) | Compound with gastric acid inhibitory effect and process for its preparation. | |
AU4304596A (en) | A process for the preparation of substituted 4-ethyl-piperidines and an intermediate for the preparation of same | |
CA2015632A1 (en) | Stable solutions of rebeccamycin analog and preparations thereof | |
DE69318715D1 (de) | Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate | |
RU95105249A (ru) | Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения | |
EP0335446A3 (en) | Agents for treating neoplasms | |
JPS5659707A (en) | Lasting antibiotic pharmaceutical and its preparation | |
DE69416034T2 (de) | Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen | |
JPS57136503A (en) | Expellent for noxious mollusk | |
RU94029664A (ru) | Новые производные 11-бензальдоксимэстра-4-9-диена, способ их получения и содержащие эти соединения лекарственные средства |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20070729 |